Pain-ridden Canadians conflicted about pills
Made-in-Canada innovation brings newfound efficacy to topical pain creams, deemed "game-changer" by legendary Hall of Famer Bobby Orr
VIDEO B-ROLL AVAILABLE
TORONTO, Sept. 9, 2012 /CNW/ - The following video is available by satellite or by CNW's Video On-Demand web download:
A new study has discovered a staggering 90 per cent of Canadians have purchased pain medication or treatments last year alone. These are some of the newly released findings from The Canadian Pain Management Report study, commissioned by Delivra Inc., an innovative bio-medical research company. The survey was conducted on the Angus Reid Forum in August 2012.
Though Canada may be a pain-ridden country, Canadians seem conflicted about pain pills. The survey found 74 per cent of Canadians said they avoid taking pain pills due to concerns such as adverse side effects.
Revered Canadian hockey legend Bobby Orr counts himself among this group of Canadians. He said it had become a norm for him to live with pain every day.
Canadian scientist Dr. Joseph Gabriele has worked to develop Delivra, the groundbreaking transdermal delivery system that transfers active ingredients through the skin to joints, muscles and other tissues, that, to date, no other topical creams have been able to reach. This innovation is poised to forever change treatment options for patients in need of alternative pain relief remedies.
As a result, Delivra's new line of topical pain relief creams, LivRelief and LivSport stand apart from the efficacy of other over-the-counter creams. Results in clinical testing have been unprecedented.
The Canadian Pain Management Report and the launch of LivRelief products across Canada come on the heels of a government announcement, investing funds into the further development of Delivra. Thanks to this investment, Delivra will conduct new research in its laboratory to be unveiled September 10th at the National Research Council of Canada Industrial Partnership Facility in Charlottetown, P.E.I.
Other applications for Delivra show great potential for health and beauty products, medications and anti-aging. In the future, Delivra may be able to provide the same anti-aging benefits in a topical cream that people can only get from cosmetic injectables today. There are a multitude of potential applications for this technology, with global implications.
Footage of adults experiencing pain, taking oral medication, applying cream
Laboratory footage and unveiling at the National Research Council of Canada Industrial Partnership Facility in PEI
Footage of Bobby Orr playing hockey
Graphic: Canadian Pain Management Report by Delivra: findings
Dr. Joseph Gabriele, President and Chief Scientific Officer, Delivra Inc.
Bobby Orr, Hall of Famer and former NHL player
The Honourable Gary Goodyear, Minister of State for Science and Technology and the Federal Economic Agency for Southern Ontario
The Honourable Robert Ghiz, Premier of Prince Edward Island
The following B-roll is available at the listed times and coordinates:
|DATE OF FEED:||Monday September 10, 2012|
|TIME OF FEED:||1:30 PM EST|
GALAXY 3C K06 Slot A (18MHz)
Downlink: 11805.5000 H
WEB Video Preview and Download link:
|TIME OF POSTING:||Approximately 3:00 PM EST|
|DATE OF POSTING:||Monday September 10, 2012|
All video can be viewed by clicking on the link. Broadcast quality video is available for download by accredited journalists. Please contact firstname.lastname@example.org for access.
STATIONS, FOR FURTHER INFORMATION:
Keka DasGupta at email@example.com or at 416 972 7727.
For technical information DURING the feed, or for assistance with Video On-Demand, please contact CNW at firstname.lastname@example.org or (416) 863-5612.
CNW Video On-Demand http://cnw.pathfireondemand.com provides free, secure and easy-to-use broadcast quality material direct from our website to accredited journalists worldwide.
SOURCE: DelivraFor further information:
CNW VIDEO SERVICES, TORONTO (416) 863-5612